Barclays’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.22M | Buy |
|
|||||
|
2025
Q2 | $3.58M | Buy |
|
|||||
|
2025
Q1 | $591K | Sell |
|
|||||
|
2024
Q4 | $713K | Buy |
|
|||||
|
2024
Q3 | $360K | Buy |
|
|||||
|
2024
Q2 | $74K | Sell |
|
|||||
|
2024
Q1 | $384K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $61K | Sell |
|
|||||
|
2021
Q4 | $643K | Buy |
|
|||||
|
2021
Q3 | $542K | Buy |
|
|||||
|
2021
Q2 | $642K | Sell |
|
|||||
|
2021
Q1 | $804K | Buy |
|
|||||
|
2020
Q4 | $458K | Sell |
|
|||||
|
2020
Q3 | $463K | Buy |
|
|||||
|
2020
Q2 | $1.83M | Buy |
|
|||||
|
2020
Q1 | $1.01M | Sell |
|
|||||
|
2019
Q4 | $1.08M | Buy |
|
|||||
|
2019
Q3 | $467K | Sell |
|
|||||
|
2019
Q2 | $628K | Buy |
|
|||||
|
2019
Q1 | $891K | Buy |
|
|||||
|
2018
Q4 | $11K | Sell |
|
|||||
|
2018
Q3 | $839K | Buy |
|
|||||
|
2018
Q2 | $148K | Sell |
|
|||||
|
2018
Q1 | $296K | Buy |
|
|||||
|
2017
Q4 | $268K | Buy |
|
|||||
|
2017
Q3 | $30K | Sell |
|
|||||
|
2017
Q2 | $199K | Buy |
|
|||||
|
2017
Q1 | $9K | Sell |
|
|||||
|
2016
Q4 | $43K | Buy |
|
|||||
|
2016
Q3 | $3K | Sell |
|
|||||
|
2016
Q2 | $4K | Buy |
|
|||||
|
2016
Q1 | $2K | Sell |
|
|||||
|
2015
Q4 | $6K | Sell |
|
|||||
|
2015
Q3 | $75K | Buy |
|
|||||
|
2015
Q2 | $6K | Buy |
|
|||||
|
2015
Q1 | $5K | Buy |
|
|||||
|
2014
Q4 | $4K | Buy |
|
|||||
|
2014
Q3 | $2K | Sell |
|
|||||
|
2014
Q2 | $67K | Buy |
|